A liposomal longevity formula delivering 500 mg of urolithin A alongside trans-resveratrol, betaine, and CoQ10 — the mitochondrial renewal compound that triggers your cells to recycle damaged energy factories and build new ones, addressing the root mechanism of cellular ageing that no antioxidant, vitamin, or lifestyle intervention can replicate.
Your cells are powered by mitochondria — thousands of tiny organelles that convert food into ATP, the energy currency every biological process depends on. When you are young, your body efficiently identifies and recycles damaged mitochondria through a process called mitophagy, replacing them with functional new ones. As you age, mitophagy slows. Damaged mitochondria accumulate. They produce less ATP and more reactive oxygen species — the metabolic waste that damages DNA, proteins, and cellular membranes from the inside out. The cascade is felt everywhere: declining energy, slower recovery, reduced muscle strength, impaired cognitive function, and the gradual erosion of cellular resilience that we experience as ageing. By your forties and fifties, you are running your body on an increasingly degraded energy infrastructure, and no amount of sleep, nutrition, or exercise can fully compensate for mitochondria that your body has stopped replacing.
The longevity supplement market has chased this problem with antioxidants for decades — vitamin C, vitamin E, CoQ10, resveratrol — each positioned as a defence against oxidative damage. And they help. But antioxidants neutralise the downstream consequences of mitochondrial dysfunction without addressing the upstream cause: the failure to remove damaged mitochondria and replace them with healthy ones. You mop the floor while the pipe keeps leaking. The fundamental problem — impaired mitophagy — remains, and the cellular energy deficit widens with every year. Until recently, the only known activator of mitophagy was caloric restriction and intense exercise. Neither is practical as a daily longevity intervention for most people.
Urolithin A changed the equation. It is a postbiotic — a compound produced when gut bacteria metabolise ellagitannins found in pomegranates, walnuts, and berries. But here is the problem: only an estimated 30 to 40% of the population has the specific gut bacteria required to produce urolithin A naturally. The rest consume pomegranates and receive negligible urolithin A regardless of how much they eat. Direct supplementation bypasses the gut microbiome bottleneck entirely. Urolithin A activates mitophagy at the cellular level — signalling your body to identify, disassemble, and recycle dysfunctional mitochondria, then stimulate the biogenesis of new, efficient replacements.
Published human clinical trials have demonstrated that urolithin A supplementation improves mitochondrial biomarkers, enhances muscle endurance, and reduces systemic inflammation. It is the first compound to directly target the mitochondrial quality control mechanism that declines with age.
Codeage delivers 500 mg of urolithin A per two-capsule serving in a liposomal matrix using non-GMO sunflower-derived phosphatidylcholine — protecting the compound through digestion for enhanced bioavailability. The formula adds trans-resveratrol (98% purity from Japanese knotweed) for sirtuin activation and additional antioxidant support, CoQ10 for mitochondrial electron transport chain function, and betaine anhydrous for methylation and cellular hydration.
Vegan capsule. Non-GMO, gluten-free, soy-free, dairy-free, keto-friendly. 60 capsules per bottle — a one-month supply.
People who understand that ageing is fundamentally a mitochondrial quality control problem choose the compound that directly activates the recycling process your body has been neglecting. It signals a longevity approach that addresses the mechanism, not just the symptoms — clearing out the damaged energy factories rather than simply defending against the damage they produce.
Profile to connect your wearables, biomarkers and test results. Create a bespoke plan based on your unique biology. Expert-led, evidence-based.
